- PharmD 2019, Chapman University School of Pharmacy
- Pharmacy-Based Travel Medicine, American Pharmacist’s Association, 2019
- Teaching Certificate, Chapman University School of Pharmacy, 2020
- APh (Advanced Practice Pharmacist), 2022
- BCACP (Board Certified Ambulatory Care Pharmacist), 2023
- PGY1 Residency Ambulatory Care Focused Pharmacy Practice 2020, Cedars-Sinai Medical Network/Chapman University School of Pharmacy
- PGY2 Ambulatory Care (Endocrinology) and Academia Focused 2021, Cedars-Sinai Medical Network/Chapman University School of Pharmacy
- Clinical Pharmacist, Resident Coordinator, Cedars Sinai Medical Network 2021-2022
- Adjust Assistant Professor of Pharmacy, Chapman University School of Pharmacy 2019-2022
- Adjust Assistant Professor of Pharmacy, Touro University California College of Pharmacy, 2021-2022
- CSHP Innovating Pharmacy Practice Award, 2020
- CUSP Resident Teacher of the Year Award, 2019-2020
- American Association of Colleges of Pharmacy Walmart Scholar, 2019
- California Pharmacy Student Leadership (CAPSLEAD)
- American Society for Preventative Cardiology (ASPC)
- The Association of Diabetes Care and Education Specialists (ADCES)
- American College of Clinical Pharmacy (ACCP)
- American Association of Colleges of Pharmacy (AACP)
- American Heart Association (AHA)
- Obesity Medicine Association (OMA)
- Phi Delta Chi
- Phi Lamda Sigma
- Rho Chi
- Symptoms Related to Ears, Nose, and Throat (book chapter). Patient Assessment for Pharmacists. In progress.
- Andraos J, Smith S, Tran A, Pham D. Narrative Review of Data Supporting Alternate First-Line Therapies Over Metformin in Type 2 Diabetes. Nature Reviews Endocrinology. Journal of Diabetes & Metabolic Disorders. March 2024.
- Andraos J, Muhar H, Smith S. “Beyond Glycemia – Comparing Tirzepatide to GLP-1 Analogues.” Reviews in Endocrine and Metabolic Disorders. August 2023.
- Zeiger A, Andraos J, Sharma A, Roosan M. “Pharmacogenomic Considerations in Opioid Therapy”. U.S. Pharmacist. April 2022.
- John Andraos, Luma Munjy &; Michael S. Kelly (2021): Home blood pressure monitoring to improve hypertension control: a narrative review of international guideline recommendations, Blood Pressure, DOI: 10.1080/08037051.2021.1911622
- Kelly M, Andraos J, Zeiger A. “Is dapagliflozin aDAPtAble to treating reduced EF heart failure?” iForumRx commentary, podcast on DAPA-HF trial. December 2019.
- Munjy L, Bethishou L, Andraos J. “Shingrix Revaccination and Vaccination in Vulnerable Populations”. Pharmacy Times. March 2019.